APM
EPIX

Avidity Partners Management’s ESSA Pharma EPIX Stock Holding History

Avidity Partners Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,855,400
Closed -$4.68M – 87
2022
Q4 		$4.68M Sell
1,855,400
-604,600
-25% -$1.74M 0.1% 70
2022
Q3 		$4.48M Hold
2,460,000
– – 0.09% 82
2022
Q2 		$7.75M Hold
2,460,000
– – 0.18% 53
2022
Q1 		$15.2M Hold
2,460,000
– – 0.32% 57
2021
Q4 		$34.9M Buy
2,460,000
+10,000
+0.4% +$111K 0.74% 43
2021
Q3 		$19.6M Sell
2,450,000
-300,000
-11% -$4.77M 0.43% 54
2021
Q2 		$78.6M Sell
2,750,000
-90,000
-3% -$2.62M 2.12% 13
2021
Q1 		$82.5M Buy
2,840,000
+282,000
+11% +$6.56M 2.28% 10
2020
Q4 		$30.5M Buy
2,558,000
+470,200
+23% +$3.31M 0.99% 37
2020
Q3 		$14.4M Buy
+2,087,800
New +$14.2M 0.67% 41

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

Avidity Partners Management's EPIX Position: Q1 2023 in Review

Avidity Partners Management sold out of ESSA Pharma (EPIX) in Q1 2023, closing a stake of 1,855,400 shares — an estimated $4.68M sold.

Avidity Partners Management first reported a position in EPIX in Q3 2020 and held it in 10 quarters. The position peaked at $82.5M in Q1 2021. 37 funds tracked by Wall St. Rank hold EPIX as of Q1 2023.

  • Avidity Partners Management reported no remaining ESSA Pharma position as of Q1 2023 after selling out during the quarter.
  • Avidity Partners Management sold 1,855,400 ESSA Pharma shares in Q1 2023, an estimated $4.68M.
  • Avidity Partners Management first reported a position in ESSA Pharma in Q3 2020 and held it in 10 quarters.
  • Avidity Partners Management's ESSA Pharma position peaked at $82.5M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2023.

Based on Avidity Partners Management's 13F filing for Q1 2023, filed 15 May 2023.